FDA monthly preview: Key September decisions to watch
-
By
-
Kathryn Wighton
-
August 28, 2026
-
5 min
By
Kathryn Wighton
August 28, 2026
Research highlights expanding diagnostic capabilities but persistent gaps in antiviral therapy and vaccine coverage for pediatric enterovirus infections.
September 8, 2026
The radioactive diagnostic drug is indicated in patients aged 1 month or older and is used in conjunction with other diagnostic evaluations.
September 14, 2026